← Back to Search

Smart Reminders for Treatment Compliance

N/A

Recruiting

Research Sponsored by Florida State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

65 years of age or older

Be older than 65 years old

Must not have

History of Parkinson's, Alzheimer's disease, or any other neurodegenerative disease

Severe motor impairment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if an adaptive reminder system can help older adults stick to home-based cognitive training better than a typical reminder system.

Who is the study for?

This trial is for older adults who are at least 65 years old with normal or corrected vision and can pass a dementia screening. It's not suitable for those with blindness, deafness, reading difficulties below the 6th-grade level, Parkinson's, Alzheimer's, other neurodegenerative diseases, terminal illness, severe motor issues or those not in Tallahassee for 6 months.

What is being tested?

The study is testing if an adaptive and personalized reminder system (APPT) can improve adherence to home-based cognitive training compared to standard reminders among older adults. The goal is to see which method better supports regular participation in the training.

What are the potential side effects?

Since this trial involves reminder systems rather than medications or invasive procedures, traditional side effects are not expected. Participants may experience frustration or stress related to technology use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a history of Parkinson's, Alzheimer's, or another neurodegenerative disease.

Select...

I have significant difficulty moving or controlling my movements.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adherence (holidays)

Adherence (session length)

Adherence (session number)

Secondary study objectives

Busyness Scale (predictor of adherence)

Dementia Worry (predictor of adherence)

Objective Cognition (predictor of adherence)

+5 more

Other study objectives

Interview

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Smart Adherence Support ConditionExperimental Treatment1 Intervention

To promote adherence, participants will receive reminders when home-based cognitive training has not been completed. This will be in the form of a text message to participants' smart phone. In this condition, participants will receive adaptive and tailored reminders based on dynamic algorithms that deploy reminders in a way that considers participant preferences, days and times of previous successful assessments, the success of previous reminder attempts, and answers to brief questions contained within reminder prompts. Parameter weights for these variables will be adjusted dynamically over a 6-month assessment period to ensure that reminders are deployed when they are most likely to be acted upon.

Group II: Reminder Only ConditionActive Control1 Intervention

To promote adherence, participants will receive generic reminders when home-based cognitive training has not been completed. This will be in the form of a text message to participants' smart phone.

0 / 3Eligibility criteria met